Fred Hassan
CIK 1110744 · Chairman and CEO · last filed 2026-06-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$14.34M
Companies
10
Total Filings
86
Lifetime Open-Market Net
$5.00M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BBIO | Director | 29,879 | $85.55 | $2.56M | $273.4K | 7 | 2026-06-24 |
| PGEN | Director | 1,243,239 | $5.53 | $6.88M | $998.1K | 14 | 2026-03-16 |
| COCP | Director | 1,383,009 | $0.93 | $1.29M | $0 | 4 | 2026-01-13 |
| EYPT | Director | — | $11.96 | — | $0 | 3 | 2026-01-06 |
| Prometheus Biosciences, Inc. (RXDX) Delisted | Director | 0 | $199.92 | $0 | $0 | 5 | 2023-06-16 |
| AMGN | Director | 9,191 | $393.10 | $3.61M | $501.6K | 7 | 2020-05-07 |
| PRECIGEN, INC. (XON) Delisted | Director | 32,358 | — | — | $200.3K | 6 | 2019-03-26 |
| WARNER MEDIA, LLC (TWX) Delisted | Director | 0 | — | — | $1.01M | 22 | 2018-06-18 |
| AVON PRODUCTS INC (AVP) Delisted | Director | 49,079 | — | — | $0 | 8 | 2012-05-07 |
| MRK | Chairman and CEO | 0 | $131.82 | $0 | $2.01M | 8 | 2009-11-04 |
Recent Filings · Page 2 of 9
86 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-09-05 | EYPT | Grant (A) | — | $0 | EDGAR |
| 2024-06-25 | BBIO | Grant (A) | — | $0 | EDGAR |
| 2024-03-18 | PGEN | Grant (A) | +44,055 | $63.0K | EDGAR |
| 2024-03-12 | PGEN | Exer (M) | +106,837 | $0 | EDGAR |
| 2023-08-16 | PGEN | Buy (P) | +570,345 | $998.1K | EDGAR |
| 2023-07-20 | COCP | Grant (A) | — | $0 | EDGAR |
| 2023-06-23 | BBIO | Grant (A) | — | $0 | EDGAR |
| 2023-06-16 | Prometheus Biosciences, Inc. (RXDX) Delisted | Disp (D) | −2,123 | $0 | EDGAR |
| 2023-05-19 | Prometheus Biosciences, Inc. (RXDX) Delisted | Grant (A) | +2,123 | $0 | EDGAR |
| 2023-03-13 | PGEN | Grant (A) | +48,290 | $56.5K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.